Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graves' Ophthalmopathy (GO)”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Testing effectiveness (Phase 2)Ended earlyNCT03938545
What this trial is testing

ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )

Who this might be right for
Graves' Ophthalmopathy (GO)
Immunovant Sciences GmbH 65
Post-approval studies (Phase 4)Looking for participantsNCT05126147
What this trial is testing

Hydroxychloroquine in Mild Graves' Orbitopathy

Who this might be right for
Graves Ophthalmopathy
National Taiwan University Hospital 108
Not applicableStudy completedNCT05345119
What this trial is testing

Sirolimus in Graves' Orbitopathy

Who this might be right for
Graves Ophthalmopathy
University of Pisa 30
Not applicableEnrolling By InvitationNCT06693856
What this trial is testing

Multi-center Prospective Clinical Study on Glucocorticoid Pulse Therapy for Graves' Ophthalmopathy (GO)

Who this might be right for
Graves Ophthalmopathy
Zou Junjie 120
Large-scale testing (Phase 3)Not Yet RecruitingNCT05049603
What this trial is testing

Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study

Who this might be right for
Graves' Orbitopathy
University of Pisa 102
Not applicableStudy completedNCT03195296
What this trial is testing

T and B Cells in Graves' Orbitopathy

Who this might be right for
Graves Ophthalmopathy
University of Pisa 20
Large-scale testing (Phase 3)Study completedNCT01297699
What this trial is testing

Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)

Who this might be right for
Thyroid Associated OphthalmopathiesGraves´ OphthalmopathyThyroid Eye Disease
Hospital Clinico Universitario de Santiago 32
Large-scale testing (Phase 3)UnknownNCT04776993
What this trial is testing

A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy

Who this might be right for
Graves' Orbitopathy
University of Pisa 52
Testing effectiveness (Phase 2)UnknownNCT04598815
What this trial is testing

Sirolimus for Graves' Orbitopathy (GO)

Who this might be right for
Graves Ophthalmopathy
University of Pisa 54
Testing effectiveness (Phase 2)Study completedNCT03110848
What this trial is testing

Effects of Atorvastatin in Graves' Orbitopathy (GO)

Who this might be right for
Thyroid Associated OphthalmopathyHypercholesterolemia
University of Pisa 88
Large-scale testing (Phase 3)Looking for participantsNCT03131726
What this trial is testing

Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)

Who this might be right for
Graves OphthalmopathyThyroid Associated OphthalmopathyThyroid Associated Orbitopathy
Lund University 80
Testing effectiveness (Phase 2)Study completedNCT03922321
What this trial is testing

Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO)

Who this might be right for
Graves' Ophthalmopathy
Immunovant Sciences GmbH 7